These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 8394911

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Opioid profiles of Cys2-containing enkephalin analogues.
    Pencheva N, Milanov P, Vezenkov L, Pajpanova T, Naydenova E.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):249-56. PubMed ID: 15364002
    [Abstract] [Full Text] [Related]

  • 3. Influence of peptidase inhibitors on the apparent agonist potency of delta selective opioid peptides in vitro.
    Kramer TH, Toth G, Haaseth RC, Matsunaga TO, Davis P, Hruby VJ, Burks TF.
    Life Sci; 1991 Sep 13; 48(9):881-6. PubMed ID: 1847736
    [Abstract] [Full Text] [Related]

  • 4. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R, Wilkes BC, Chung NN, Lemieux C, Schiller PW.
    Int J Pept Protein Res; 1996 Nov 13; 48(5):411-9. PubMed ID: 8956074
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacologic evaluation of a cyclic somatostatin analog with antagonist activity at mu opioid receptors in vitro.
    Shook JE, Pelton JT, Wire WS, Hirning LD, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1987 Mar 13; 240(3):772-7. PubMed ID: 2882015
    [Abstract] [Full Text] [Related]

  • 7. Opioid antagonist properties of the highly delta-receptor-selective BOC-Tyr-Pro-Gly-Phe-Leu-Thr (OtBu) peptide and of its Phe1 and Mel1 analogues.
    Rónai AZ, Magyar A, Orosz G, Borsodi A, Benyhe S, Tóth G, Makó E, Kátay E, Babka E, Medzihradszky K.
    Arch Int Pharmacodyn Ther; 1995 Mar 13; 330(3):361-9. PubMed ID: 8836454
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity.
    Horan PJ, Wild KD, Misicka A, Lipkowski A, Haaseth RC, Hruby VJ, Weber SJ, Davis TP, Yamamura HI, Porreca F.
    J Pharmacol Exp Ther; 1993 May 13; 265(2):896-902. PubMed ID: 8388462
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens.
    Wild KD, Carlisi VJ, Mosberg HI, Bowen WD, Portoghese PS, Sultana M, Takemori AE, Hruby VJ, Porreca F.
    J Pharmacol Exp Ther; 1993 Feb 13; 264(2):831-8. PubMed ID: 8382281
    [Abstract] [Full Text] [Related]

  • 13. Characterization of kappa and delta opioid receptors in isolated organs by using type/subtype selective agonists and antagonists.
    Makó E, Rónai AZ.
    Med Sci Monit; 2001 Feb 13; 7(3):350-6. PubMed ID: 11386008
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S, Khare NK, Saini SK, Seitz LE, Bartlett JL, Davis P, Dersch CM, Porreca F, Rothman RB, Bilsky EJ.
    J Med Chem; 2004 Mar 11; 47(6):1400-12. PubMed ID: 14998329
    [Abstract] [Full Text] [Related]

  • 17. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S, Kezar HS, Carter RL, Saini SK, Rice KC, Wells JL, Davis P, Xu H, Dersch CM, Bilsky EJ, Porreca F, Rothman RB.
    J Med Chem; 1999 Sep 09; 42(18):3527-38. PubMed ID: 10479286
    [Abstract] [Full Text] [Related]

  • 18. Cyclic enkephalin analogs containing various para-substituted phenylalanine derivatives in place of Tyr1 are potent opioid agonists.
    Weltrowska G, Lemieux C, Chung NN, Schiller PW.
    J Pept Res; 2005 Jan 09; 65(1):36-41. PubMed ID: 15686532
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.